Home > Insider Trading > Filing (0001104659-15-044671)

Filing Details

Accession Number:: 0001104659-15-044671
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-10 18:01:20
Reporting Period:: 2015-06-08

Filing Date:: 2015-06-10
Accepted Time:: 2015-06-10 18:01:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070081	Ptc Therapeutics Inc.	PTCT	Pharmaceutical Preparations (2834)	043416587

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1578962	Walter Stuart Peltz	C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-06-08	60,306	$10.85	60,306	No	4	M	Direct
Common Stock	Acquisiton	2015-06-08	17,170	$10.85	77,476	No	4	M	Direct
Common Stock	Disposition	2015-06-08	11,825	$53.81	65,651	No	4	S	Direct
Common Stock	Disposition	2015-06-08	36,075	$54.64	29,576	No	4	S	Direct
Common Stock	Disposition	2015-06-08	22,300	$55.71	7,276	No	4	S	Direct
Common Stock	Disposition	2015-06-08	3,500	$56.40	3,776	No	4	S	Direct
Common Stock	Acquisiton	2015-06-09	26,300	$10.85	30,076	No	4	M	Direct
Common Stock	Disposition	2015-06-09	12,500	$52.89	17,576	No	4	S	Direct
Common Stock	Disposition	2015-06-09	13,400	$53.64	4,176	No	4	S	Direct
Common Stock	Disposition	2015-06-09	400	$54.29	3,776	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2015-06-08	60,306	$0.00	60,306	$10.85
Common Stock	Stock Option (Right to Buy)	Disposition	2015-06-08	17,170	$0.00	17,170	$10.85
Common Stock	Stock Option (Right to Buy)	Disposition	2015-06-09	26,300	$0.00	26,300	$10.85

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
110,694	2023-05-15	No	4	M	Direct
382,830	2023-05-15	No	4	M	Direct
356,530	2023-05-15	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$27.05	2024-01-27	200,000	200,000	Direct
Common Stock	Stock Option (Right to Buy)	$51.00	2025-01-01	300,000	300,000	Direct
Common Stock	Stock Option (Right to Buy)	$218.40	2022-01-10	416	416	Direct
Common Stock	Stock Option (Right to Buy)	$490.80	2021-04-27	541	541	Direct
Common Stock	Stock Option (Right to Buy)	$1,149.60	2020-02-02	583	583	Direct
Common Stock	Stock Option (Right to Buy)	$451.20	2019-05-15	583	583	Direct
Common Stock	Stock Option (Right to Buy)	$735.60	2018-04-01	293	293	Direct
Common Stock	Stock Option (Right to Buy)	$735.60	2018-01-25	708	708	Direct
Common Stock	Stock Option (Right to Buy)	$626.40	2017-04-18	322	322	Direct
Common Stock	Stock Option (Right to Buy)	$392.40	2016-03-01	136	136	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-01-27	200,000	200,000	Direct
2025-01-01	300,000	300,000	Direct
2022-01-10	416	416	Direct
2021-04-27	541	541	Direct
2020-02-02	583	583	Direct
2019-05-15	583	583	Direct
2018-04-01	293	293	Direct
2018-01-25	708	708	Direct
2017-04-18	322	322	Direct
2016-03-01	136	136	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person for the primary purposes of diversification.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.26 to $54.25 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.26 to $55.18 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.26 to $56.12 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.26 to $56.59 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.23 to $53.21per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.23 to $54.22 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.25 to $54.30 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
This option was granted on January 28, 2014 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2013.
Currently exercisable.